Refractory polymyositis responding to infliximab: extended follow-up

Abstract
Sir, The management of patients with dermatomyositis (DM) or polymyositis (PM) who fail to respond durably to conventional treatments remains difficult [1, 2]. We report the case of a 63-yr-old woman with refractory PM that dramatically responded to the addition of anti-TNF-α agent infliximab.

This publication has 0 references indexed in Scilit: